Plus Therapeutics
$0.15
206
-$0.01-6.09% Today
Statistics
Day High
0.15
Day Low
0.13
52W High
1.22
52W Low
0.13
Volume
18,876,752
Avg. Volume
9,749,265
Mkt Cap
20.99M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
16AprExpected
Expected EPS
-0.0325
Actual EPS
N/A
Financials
-222.84%Profit Margin
Unprofitable11.65MRevenue
-25.96MNet Income
Analyst Ratings
$10.00Average Price Target
The highest estimate is 19.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PSTV. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Mustang Bio
MBIO
Mkt Cap10.5M
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
Fate Therapeutics
FATE
Mkt Cap155.7M
Allogene Therapeutics
ALLO
Mkt Cap275.13M
About
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
Show more...
CEO
Dr. Marc H. Hedrick M.B.A., M.D.
Employees
21
Country
US
ISIN
US72941H5090
Listings
0 Comments
Share your thoughts
FAQ
What is Plus Therapeutics stock price today?▼
The current price of PSTV is $0.15 USD — it has decreased by -6.09% in the past 24 hours. Watch Plus Therapeutics stock price performance more closely on the chart.
What is Plus Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Plus Therapeutics stocks are traded under the ticker PSTV.
Is Plus Therapeutics stock price growing?▼
PSTV stock has fallen by -40.02% compared to the previous week, the month change is a -51.27% fall, over the last year Plus Therapeutics has showed a -85.54% decrease.
What is Plus Therapeutics market cap?▼
Today Plus Therapeutics has the market capitalization of 20.99M
When is the next Plus Therapeutics earnings date?▼
Plus Therapeutics is going to release the next earnings report on April 16, 2026.
What were Plus Therapeutics earnings last quarter?▼
PSTV earnings for the last quarter are -0.04 USD per share, whereas the estimation was -0.02 USD resulting in a -100% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Plus Therapeutics revenue for the last year?▼
Plus Therapeutics revenue for the last year amounts to 11.65M USD.
What is Plus Therapeutics net income for the last year?▼
PSTV net income for the last year is -25.96M USD.
How many employees does Plus Therapeutics have?▼
As of April 01, 2026, the company has 21 employees.
In which sector is Plus Therapeutics located?▼
Plus Therapeutics operates in the Health Care sector.
When did Plus Therapeutics complete a stock split?▼
The last stock split for Plus Therapeutics was on May 01, 2023 with a ratio of 1:15.
Where is Plus Therapeutics headquartered?▼
Plus Therapeutics is headquartered in Houston, US.